Papachristos Danae A, Huynh Jenny, Grossman Mathis, MacIsaac Richard J
Department of Endocrinology and Diabetes, St Vincent's Hospital-Melbourne, Melbourne, VIC, Australia.
Endocrine Centre of Excellence, Austin Health, Melbourne, VIC, Australia; Department of Medicine, University of Melbourne, Melbourne, VIC, Australia.
SAGE Open Med Case Rep. 2015 Jan 19;3:2050313X14568335. doi: 10.1177/2050313X14568335. eCollection 2015.
Thioamides have been used in the management of hyperthyroidism for over 50 years. Liver dysfunction is a rare but important side effect associated with their use. Recently, cases of liver failure associated with propylthiouracil have prompted the Federal Drug Administration to issue a Boxed Warning to the label of propylthiouracil regarding its risk of potentially fatal liver injury and acute liver failure in adults and children. Herein, we present a case to underline the importance of recognising the similar potential for severe hepatic dysfunction with the use of other thioamides.
硫代酰胺类药物用于治疗甲状腺功能亢进已有50多年。肝功能障碍是与其使用相关的一种罕见但重要的副作用。最近,丙硫氧嘧啶相关的肝衰竭病例促使美国食品药品监督管理局在丙硫氧嘧啶的标签上发布了黑框警告,提示其在成人和儿童中存在潜在致命性肝损伤及急性肝衰竭的风险。在此,我们报告一例病例,以强调认识到使用其他硫代酰胺类药物时发生严重肝功能障碍的类似潜在风险的重要性。